NovoRapid® Penfill®

DRUG2 trials

Sponsors

Geropharm

Conditions

Clamp StudyDiabetesDiabetes Mellitus, Type 1

Phase 3

Efficacy and Safety of GP40071 Compared to NovoRapid® Penfill® in Type 1 Diabetes Mellitus Patients

CompletedNCT04079413

GeropharmDiabetes, Diabetes Mellitus, Type 1

Start: 2019-06-03End: 2020-01-21Updated: 2020-07-23

Unknown Phase

A Study to Compare Pharmacokinetics and Pharmacodynamics of Insulin Aspart to NovoRapid® Penfill® in Healthy Subjects

CompletedNCT04184466

GeropharmClamp Study

Start: 2018-10-18End: 2018-12-19Updated: 2019-12-03

Related Papers

Safety and efficacy of GP40071 compared with originator insulin aspart (NovoRapid <sup>®</sup> Penfill <sup>®</sup> ) in Type 1 diabetes mellitus

Journal of Comparative Effectiveness Research2021-04-308 citations